BioMed Research International / 2014 / Article / Tab 6

Clinical Study

Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy

Table 6

Univariate prognostic analysis.

Prognostic factors LCDFSDSSOS
%%%%

Gender
 Male89.60.17674.60.13383.70.09676.20.041
 Female91.072.181.178.7
Age (years)
 ≦45 92.40.85375.50.73784.40.58978.80.745
 >45 87.172.581.875.4
T
 T1/291.50.88785.7<0.00092.8<0.00183.00.012
 T3/488.966.877.273.5
N
 N0/193.50.71880.60.00490.5<0.00182.30.021
 N2/388.670.578.373.7
Clinical stage
I + II93.50.12379.50.03691.50.00889.5<0.001
III + IV88.071.278.870.7
Radiotherapy interruption
 ≦10 d92.60.00075.60.00084.90.00079.40.000
 >10 d76.364.171.862.8
HGB (g/L)
 ≦11077.00.00063.30.00073.3<0.00170.0<0.001
 >11091.475.384.378.0
Percentage of weight loss
 ≦10%90.90.09275.60.52586.50.15380.50.011
 >10%85.672.479.673.5
Chemotherapy or not given
 IMRT88.90.38572.20.20481.80.08772.70.043
 Chemo. + IMRT90.475.083.979.4

HGB: hemoglobin; LC: local-regional control rates; DFS: disease-free survival; DSS: disease specific survival; OS: overall survival rate.